Evidence map›Paper›PMID 39180560›Full record

ArticleArchives of dermatological research2024

Clinical efficacy of 595 nm pulsed dye laser in combination with supramolecular salicylic acid in the treatment of rosacea.

Wei Lei, Huang Chen, Liuqing Chen, Meng Li, Jun Zhang, Xuegang Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of dermatological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wei LeiDepartment of Dermatology, No. 1 Hospital of Wuhan, Wuhan, 430000, Hubei, China.
Huang ChenDepartment of Cosmetic Dermatology, Shenzhen Coastal Medical Beauty Clinic, Shenzhen, 518064, Guangdong, China.
Liuqing ChenDepartment of Dermatology, No. 1 Hospital of Wuhan, Wuhan, 430000, Hubei, China.
Meng LiDepartment of Dermatology, No. 1 Hospital of Wuhan, Wuhan, 430000, Hubei, China.
Jun ZhangDepartment of Dermatology, No. 1 Hospital of Wuhan, Wuhan, 430000, Hubei, China.
Xuegang XuDepartment of Dermatology, No.1 Hospital of China Medical University, 155 North Nanjing Street, Shenyang, 110001, Liaoning, China. Xuxuegang2606@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis research was aimed at ascertaining the clinical effects of 595 nm pulsed dye laser (PDL) in combination with supramolecular salicylic acid (SSA) in the treatment of rosacea.

methodsEighty-four patients with rosacea were selected, of which 42 patients treated with PDL alone were considered as the control group, and 42 patients treated with 595 nm PDL in combination with 30% SSA were regarded as the observation group. The treatment continued for 4 months in the two groups. Clinical symptom scores, skin barrier function indicators, serum inflammatory factors, Acne⁃QOL scores and adverse reactions between the two groups were compared.

resultsAfter treatment, levels of inflammatory factors, clinical symptom scores, transdermal water loss, and oil volume were decreased, and epidermal water content and Acne-QOL scores were increased in both groups (all P < 0.05), and the changes in the observation group were more pronounced versus the control group (all P < 0.05). The difference in the incidence of adverse reactions was not statistically significant between the two groups (P > 0.05).

conclusion595 nm PDL in combination with SSA is safe in the treatment of rosacea.

Indexed as

Lasers, DyeRosaceaSalicylic AcidAdultCombined Modality TherapyFemaleHumansLow-Level Light TherapyMaleMiddle AgedQuality of LifeSkinTreatment OutcomeYoung AdultSalicylic AcidInflammatory factorsPulsed dye laserRosaceaSkin barrier functionSupramolecular salicylic acid

Identifiers

PMID39180560

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.